![Christopher Heberlig](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Heberlig
Finanzdirektor/CFO bei KSQ Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Christopher Heberlig
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Extinct | Biotechnology | 30 | |
Subsidiary | Pharmaceuticals: Major | 28 | |
Public Company | Biotechnology | 9 | |
KSQ Therapeutics, Inc.
![]() KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Christopher Heberlig
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer General Counsel Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Kiniksa Pharmaceuticals Corp.
![]() Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of The Vanguard Group, Inc., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Ardea Biosciences, Inc.
![]() Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Founder Chief Operating Officer Director/Board Member | |
Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
Rochester Christian University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
SYROS PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
GENOMIC HEALTH, INC. | Medical Specialties | Director/Board Member Chief Executive Officer | |
KODIAK SCIENCES INC. | Biotechnology | Director/Board Member Director/Board Member | |
TALIS BIOMEDICAL CORPORATION | Medical Specialties | Chairman Director/Board Member | |
University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree | |
Wallace E Carroll School of Management | College/University | Masters Business Admin Masters Business Admin | |
Boston College Law School | College/University | Graduate Degree Graduate Degree | |
VACCINEX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member Compliance Officer | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO General Counsel | |
KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Boston University | College/University | Graduate Degree Undergraduate Degree | |
HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
Harvard College | College/University | Graduate Degree Undergraduate Degree | |
SPYRE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
IMMUNOGEN, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Genzyme Therapeutics Ltd.
![]() Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
Brown University | College/University | Corporate Officer/Principal Undergraduate Degree | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
D'Amore-Mckim School of Business | College/University | Masters Business Admin Masters Business Admin | |
INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
VOYAGER THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact Director of Finance/CFO | |
BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Baker Bros. Advisors LP
![]() Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Portfolio Manager-Equities | |
MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
The Salk Institute for Biological Studies | College/University | General Counsel | |
TFMG Associates LLC | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 46 |
Israel | 2 |
Vereinigtes Königreich | 2 |
Dänemark | 2 |
Kanada | 2 |
Sektoral
Health Technology | 33 |
Consumer Services | 15 |
Commercial Services | 2 |
Finance | 2 |
Operativ
Director/Board Member | 265 |
Corporate Officer/Principal | 118 |
Independent Dir/Board Member | 96 |
Undergraduate Degree | 51 |
Chairman | 43 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Felix Baker | 29 |
Alan Crane | 29 |
Thomas Tisch | 27 |
Theo Melas-Kyriazi | 26 |
Kirk Malloy | 20 |
Kim Popovits | 20 |
Mark Kessel | 18 |
Thomas Malley | 18 |
J. Goater | 17 |
Richard Levy | 17 |
Mark Goldberg | 17 |
Carsten Boess | 15 |
Peter Wirth | 15 |
Barry Quart | 14 |
Thomas Jurgensen | 14 |
- Börse
- Insiders
- Christopher Heberlig
- Unternehmensverbindungen